(Q34123652)

31 July 2017

1 reference

title

The importance of drug interactions in epilepsy therapy (English)

1 reference

31 July 2017

Philip N Patsalos

1

1 reference

31 July 2017

Walter Fröscher

series ordinal

2

1 reference

31 July 2017

Francesco Pisani

series ordinal

3

1 reference

31 July 2017

Clementina M van Rijn

series ordinal

4

1 reference

31 July 2017

publication date

1 April 2002

1 reference

31 July 2017

1 reference

31 July 2017

volume

43

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

365-385

1 reference

Antiepileptic drug intoxication: factors and their significance

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Monotherapy clinical trials of new antiepileptic drugs: design, indications, and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Effect of sodium valproate on plasma protein binding of diphenylhydantoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Clinical importance of hepatic cytochrome P450 in drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Clinical pharmacokinetics of new antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Phenobarbitone to gabapentin: a guide to 82 years of anti-epileptic drug pharmacokinetic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Gabapentin potentiates the antiseizure activity of certain anticonvulsants in DBA/2 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

A molecular model for the synergic interaction between gamma-aminobutyric acid and general anaesthetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Complex partial seizures: EEG foci and response to carbamazepine and sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxylation and population pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Populations and genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Antiepileptic drug therapy: general treatment principles and application for special patient populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Valproic acid hepatic fatalities: a retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Teratogenicity of antiepileptic drugs: analysis of possible risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Influence of co-medication on the metabolism of valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

The teratogenicity of anticonvulsant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Kinetics of phenobarbital in normal subjects and epileptic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Clinical Pharmacokinetics of Phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Lamotrigine clinical pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Sodium valproate acutely inhibits lamotrigine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Disabling tremor after lamotrigine with sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Stupor Following Administration of Valproic Acid to Patients Receiving Other Antiepileptic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Serum-phenytoin levels in management of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Antiepileptic drugs. A review of clinically significant drug interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Effect of valpromide on the pharmacokinetics of carbamazepine-10, 11-epoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Carbamazepine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Current issues on epileptic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Pharmacokinetic drug interactions between oral contraceptives and second-generation anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Clinical pharmacology of topiramate: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Induction of CYP1A2 activity by carbamazepine in children using the caffeine breath test

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Clinically significant drug interactions with the oral anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Pharmacokinetic interactions with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

21 January 2018

New antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Oral phenytoin pharmacokinetics during omeprazole therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Differential effect of cimetidine on serum concentrations of carbamazepine and phenytoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Interactions between anticonvulsant and psychoactive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Interaction between phenytoin and imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Lamotrigine toxicity secondary to sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Clinically significant pharmacokinetic drug interactions between antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Interaction between cyclosporin A and phenobarbitone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Carbamazepine toxicity induced by concurrent erythromycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Absence of interaction between oxcarbazepine and erythromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Lack of pharmacokinetic interaction between tiagabine and erythromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

New-onset seizures associated with human immunodeficiency virus infection: causation and clinical features in 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Seizures in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Therapeutic dilemma: the use of anticonvulsants in HIV-positive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Pharmacokinetic drug interactions with cyclosporin (Part I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Oxcarbazepine: pharmacokinetic interactions and their clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Possible oxcarbazepine interaction with cyclosporine serum levels: a single case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Interactions between anticancer drugs and other clinically used pharmaceuticals. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Cytochromes P450 and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Antiepileptic drug pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

Malformations in Offspring of Women with Epilepsy: A Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.13001.X

10.1046/J.1528-1157.2002.13001.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference